CXCR4 and glioblastoma: Further, nine patients with evidence (MRI) of brain tumors were screened with SPECT after 99mTc-CXCR4-L injection, and seven of them were diagnosed as grade II oligodendroglioma, grade IV glioblastoma, grade IV gliosarcoma, metastasis, or diffuse astrocytoma.